NCT03917563 (RECORD) is a NA clinical trial of WATCHMAN LAA occluder in Non-valvular Atrial Fibrillation, sponsored by Xijing Hospital.

Who is sponsoring NCT03917563?

NCT03917563 is sponsored by Xijing Hospital.

What drugs are being tested in NCT03917563?

Interventions in NCT03917563: WATCHMAN LAA occluder.

What condition does NCT03917563 study?

NCT03917563 studies Non-valvular Atrial Fibrillation.

Is NCT03917563 still recruiting?

NCT03917563 is currently status unknown. Last updated 17 April 2019.

Last reviewed 2019-04-17 · How we verify

NCT03917563: RECORD

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Registry to Evaluate Chinese Real-World Clinical Outcomes in Patients With AF Using the WATCHMAN Left Atrial Appendage Closure Technology

Status unknown NA Last updated 17 April 2019

What this trial tests

NA trial testing WATCHMAN LAA occluder in Non-valvular Atrial Fibrillation in 1,050 participants. Status unknown.

Timeline

20 April 2019

Primary endpoint
20 April 2021

20 April 2024

Quick facts

Lead sponsor	Xijing Hospital
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	1,050
Start date	20 April 2019
Primary completion	20 April 2021
Estimated completion	20 April 2024
Sites	1 location across China

Drugs / interventions tested

WATCHMAN LAA occluder

Conditions studied

Non-valvular Atrial Fibrillation — all drugs for Non-valvular Atrial Fibrillation →

Sponsor

Xijing Hospital

Who can join

Adults 18 to 100, any sex, with Non-valvular Atrial Fibrillation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of the registry is to evaluate Chinese real-World clinical outcomes in patients With AF using the WATCHMAN left Atrial appendage closure technology

Publications & conference data

5 peer-reviewed publications reference this trial (live from Europe PMC):

Periprocedural Outcomes Associated With Use of a Left Atrial Appendage Occlusion Device in China.
Su F, Gao C, Liu J, Ning Z, et al · · 2022 · cited 21× · PMID 35639378 · DOI 10.1001/jamanetworkopen.2022.14594
1-Year Clinical Outcomes and the Impact of Procedural Configurations in Left Atrial Appendage Occlusion Patients.
Gao C, Su F, Liu J, Zhang T, et al · · 2024 · cited 2× · PMID 39553900 · DOI 10.1016/j.jacasi.2024.07.013
Impact of Operator Experience on Left Atrial Appendage Occlusion Outcomes.
Zhang T, Gao C, Liu J, Fu G, et al · · 2024 · cited 2× · PMID 39269400 · DOI 10.1016/j.jacep.2024.07.010
Three-year clinical outcomes of left atrial appendage occlusion with or without ablation: insight from the RECORD study.
Zhang T, He X, Fu G, Liu H, et al · · 2026 · cited 1× · PMID 41645487 · DOI 10.1093/europace/euag022
Three-year clinical outcomes of transcatheter left atrial appendage occlusion.
Zhang T, He X, Wang P, Fu G, et al · · 2026 · PMID 41424040 · DOI 10.1097/cm9.0000000000003909

Verify or expand the search:

Other recruiting trials for Non-valvular Atrial Fibrillation

Currently open trials in the same condition.

NCT05565599 — An Early Feasibility Study Evaluating the Safety and Efficacy of the Laminar Left Atrial Appendage Closure System in Sub · NA · active not recruiting

Other Xijing Hospital trials

Trials by the same sponsor.

NCT07532096 — Extended Sentinel Lymph Node Biopsy With Methylene Blue Single Tracer Post-Neoadjuvant Therapy for Node-Positive Breast · NA · not yet recruiting
NCT07519018 — TIS for Drug Resistant TLE · NA · not yet recruiting
NCT07518992 — Correlation Between Preoperative Sleep and Postoperative Brain and Renal Dysfunction · not yet recruiting
NCT07466303 — Serplulimab Combined With Trastuzumab Rezetecan as Neoadjuvant Therapy for Triple-Negative Breast Cancer · Phase 2 · not yet recruiting
NCT07474142 — A Multicenter, Prospective Study on the Prognostic Value of PSMA PET in Patients With Newly Diagnosed, Treatment-naïve P · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03917563 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Xijing Hospital
Last refreshed: 17 April 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03917563.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing